Follow

Health Care Viewpoints Blog

Articles: 1-10 of 1110

New York City's Health Care Price Transparency Law Takes Effect

USA - February 29 2024 In summer of 2023, New York City Mayor Eric Adams signed Intro. 844-A (Local Law 844-A) and amended the New York City Charter. Local Law 844-A…

CMS Releases Part Two of Guidance for the Inflation Reduction Act’s Medicare Prescription Payment Plan

USA - February 27 2024 On February 15, 2024, the Centers for Medicare and Medicaid Services (CMS) released the Medicare Prescription Payment Plan Draft Part Two Guidance…

California’s Health Care Transactions Review Law: Preparing for What Comes Next

USA - February 26 2024 California’s health omnibus trailer bill SB-184 and the final cost and market impact review (CMIR) regulations (CMIR Regulations), which went into…

Mintz IRA Update — Demystifying the IRA’s Small Biotech Exception

USA - February 21 2024 On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA’s Medicare…

Mintz IRA Update — Legal Challenges to the Medicare Drug Price Negotiation Program Continue

USA - February 21 2024 The IRA’s Medicare Drug Price Negotiation Program (the “Negotiation Program” or “Program”), which aims to lower drug prices by enabling the federal…

New Mexico Latest State to Expand Medicaid Behavioral Health Program, Add Mobile Crisis Intervention Program

USA - February 21 2024 New Mexico recently became the latest state to receive Centers for Medicare & Medicaid Services (CMS) approval to expand the State’s behavioral…

Mintz IRA Update — The IRA in 2024: The Medicare Drug Price Negotiation Program in Full Swing and Other Developments

USA - February 21 2024 Our team’s preparation for the year includes a review of the anticipated impact of the IRA on the health care industry in 2024. Many of the IRA’s key…

Mintz IRA Update — Removal of AMP-Cap on Medicaid Rebates Causes Insulin Price Decrease

USA - February 21 2024 Insulin costs lowered to $35 dollars per month for many patients this year as three major insulin manufacturers — Sanofi, Novo Nordisk, and Eli Lilly…

CMS Announces New Model for the Delivery of Integrated Behavioral and Physical Health Care

USA - February 5 2024 With the goal of enhancing health care quality and outcomes for individuals with moderate to severe behavioral health conditions and substance use…

OCR Releases Long Awaited Final Rule Regarding the Conscience Protections for Religious and Moral Objections in Health Care

USA - January 29 2024 On January 11, 2024, the Office for Civil Rights (OCR) issued its highly anticipated Final Rule regarding conscience protections. The Final Rule…